Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer

BACKGROUND: The systemic immune‐inflammation index (SII) is correlated with patient survival in various types of solid tumors. However, only a few studies have focused on the prognostic value of the SII in patients with surgically resected non‐small cell lung cancer (NSCLC). METHODS: This study was...

全面介紹

Na minha lista:
書目詳細資料
發表在:Thorac Cancer
Main Authors: Guo, Wei, Cai, Songhua, Zhang, Fan, Shao, Fei, Zhang, Guochao, Zhou, Yang, Zhao, Liang, Tan, Fengwei, Gao, Shugeng, He, Jie
格式: Artigo
語言:Inglês
出版: John Wiley & Sons Australia, Ltd 2019
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6449249/
https://ncbi.nlm.nih.gov/pubmed/30734516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12995
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍